1. Describe the evolution of clinical trial design in Parkinson’s disease
  2. Describe what we need to learn about the disease and approaches to therapeutics in Parkinson’s disease neurodegeneration to move the field forward.
Session date: 
03/03/2025 - 4:00pm to 5:00pm CST
Location: 
In-person and Virtually
1685 Highland Ave
MFCB-Room 1220
United States
See map: Google Maps
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 

Please login or register to take this course.